Results of Open-label Extension of the ORIGIN Study – Explore the Visual Abstract
This visual abstract was supported by Vera Therapeutics.
09Dec
Share
Back to News
Back to News
Related Posts
12May
Amplifying global efforts to advance kidney health at WHA78
The ISN strongly supports the upcoming World Health Organization (WHO) resolution,... read more
12May
Award-winning impact from an ISN Mentorship pairing
ISN Mentee Felix-Mihai Maralescu Apply to the ISN Mentorship Program as a... read more
12May
Heading to Vicenza! ISN members win free course registration
Two ISN members have won complimentary registrations for the upcoming 43rd... read more
12May
Welcoming a new member to the ISN’s ever-growing network
The ISN has expanded its global network with the addition of... read more
12May
Pressing questions and promising developments in complement therapeutics in C3G and IgAN: ISN International Expert Forum
From May 2–4, 88 leading experts in nephrology gathered in Budapest,... read more
12May
GREEN-K: Leading the shift to sustainable global kidney care
The ISN’s pioneering efforts to address environmental challenges in kidney care... read more
12May
Results from ISN regional board-led survey on migrant access to kidney care in Europe published
Results from a survey led by Cédric Rafat and members of... read more
12May
Breaking new ground in Myanmar’s pediatric kidney care
Pediatric nephrology staff from the Yangon Children’s Hospital, the Children’s Hospital... read more
12May
ISN Journal summaries on nephrotic syndrome in children and obesity’s role in CKD
Kidney International® Executive summary of the KDIGO 2025 Clinical Practice Guideline for... read more
12May
Inside the ORIGIN study: Visual and video abstracts on atacicept for the treatment of IgA Nephropathy
Watch the video for an animated explanation of the study based... read more